Canada warns on ephedra, kava
This article was originally published in The Tan Sheet
Executive Summary
Health Canada advises Aug. 21 that two unauthorized natural health products with ephedrine and kava could cause "serious adverse health effects including death." Life Choice Ephedrine HCL "contains an excessive amount of ephedrine," which may react adversely to caffeine or other stimulants, and has been found to be contaminated with bacteria, the agency reports in a same-day release. Health Canada recalled certain ephedra products in 2002 and currently advises their use only for nasal decongestion (1"The Tan Sheet" June 16, 2003, In Brief). Consumers should also discontinue use of Life Choice Kava Kava, the agency says, due to concerns of liver toxicity related to consumption of kava products. Health Canada halted Kava product sales in August 2002 and they are also banned in the U.K. (2"The Tan Sheet" Aug. 26, 2002, In Brief and 3"The Tan Sheet" Aug. 7, 2006, In Brief)
You may also be interested in...
Canada on ephedra
Recalled ephedra items are still available "under the counter, in back rooms and at gyms," agency states in June 9 1advisory asking consumers to report such activities. Health Canada recalled certain ephedra products last year (2"The Tan Sheet" Jan. 14, 2002, p. 16)...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.